Showing results (231-240 of 319) with videos related to
Sort By:
Pageof 32
Plos One|January 25, 2022
T and NK cell lymphoma cell lines do not rely on ZAP-70 for survivalSanjay de Mel, Nurulhuda Mustafa, Viknesvaran Selvarajan, et al.Experimental Hematology & Oncology|June 2, 2020
Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myelomaXi Yun Zhang, Deepa Rajagopalan, Tae-Hoon Chung, et al.Blood Cancer Journal|February 13, 2021
Myeloma-specific superenhancers affect genes of biological and clinical relevance in myelomaYunlu Jia, Jianbiao Zhou, Tze King Tan, et al.Trends in Biotechnology|January 26, 2020
Enabling Technologies for Personalized and Precision MedicineDean Ho, Stephen R Quake, Edward R B McCabe, et al.Advances in Cell and Gene Therapy|August 25, 2020
Rapid production of clinical-grade SARS-CoV-2 specific T cellsWing Leung, Teck Guan Soh, Yeh Ching Linn, et al.Scientific Reports|May 21, 2017
Super-Enhancers and Broad H3K4me3 Domains Form Complex Gene Regulatory Circuits Involving Chromatin InteractionsFan Cao, Yiwen Fang, Hong Kee Tan, et al.Journal of Clinical Pathology|November 29, 2017
CEBPA mutational analysis in acute myeloid leukaemia by a laboratory-developed next-generation sequencing assayChristopher Wai Siong Ng, Bustamin Kosmo, Peak-Ling Lee, et al.Nature Biotechnology|July 20, 2021
Identification of differential RNA modifications from nanopore direct RNA sequencing with xPorePloy N Pratanwanich, Fei Yao, Ying Chen, et al.Journal for Immunotherapy of Cancer|July 3, 2021
Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphomaNurulhuda Mustafa, Adina Huey Fang Nee, Jing Yuan Chooi, et al.Blood Cancer Journal|August 13, 2021
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphomaShin Yeu Ong, Sanjay de Mel, Nicholas Francis Grigoropoulos, et al.Pageof 32